Arcutis Biotherapeutics Statistics
Total Valuation
ARQT has a market cap or net worth of $3.22 billion. The enterprise value is $3.09 billion.
| Market Cap | 3.22B |
| Enterprise Value | 3.09B |
Important Dates
The last earnings date was Wednesday, November 4, 2026, after market close.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ARQT has 126.46 million shares outstanding. The number of shares has increased by 6.17% in one year.
| Current Share Class | 126.46M |
| Shares Outstanding | 126.46M |
| Shares Change (YoY) | +6.17% |
| Shares Change (QoQ) | +0.69% |
| Owned by Insiders (%) | 1.06% |
| Owned by Institutions (%) | 89.36% |
| Float | 93.76M |
Valuation Ratios
The trailing PE ratio is 117.58 and the forward PE ratio is 32.76.
| PE Ratio | 117.58 |
| Forward PE | 32.76 |
| PS Ratio | 6.37 |
| Forward PS | 5.08 |
| PB Ratio | 13.95 |
| P/TBV Ratio | 14.03 |
| P/FCF Ratio | 54.23 |
| P/OCF Ratio | 54.00 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 82.92, with an EV/FCF ratio of 51.96.
| EV / Earnings | 103.72 |
| EV / Sales | 6.10 |
| EV / EBITDA | 82.92 |
| EV / EBIT | 88.22 |
| EV / FCF | 51.96 |
Financial Position
The company has a current ratio of 2.92, with a Debt / Equity ratio of 0.51.
| Current Ratio | 2.92 |
| Quick Ratio | 2.50 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 3.23 |
| Debt / FCF | 2.07 |
| Interest Coverage | 2.56 |
Financial Efficiency
Return on equity (ROE) is 14.88% and return on invested capital (ROIC) is 33.39%.
| Return on Equity (ROE) | 14.88% |
| Return on Assets (ROA) | 4.91% |
| Return on Invested Capital (ROIC) | 33.39% |
| Return on Capital Employed (ROCE) | 9.99% |
| Weighted Average Cost of Capital (WACC) | 13.14% |
| Revenue Per Employee | $1.44M |
| Profits Per Employee | $84,492 |
| Employee Count | 354 |
| Asset Turnover | 1.14 |
| Inventory Turnover | 1.32 |
Taxes
In the past 12 months, ARQT has paid $894,000 in taxes.
| Income Tax | 894,000 |
| Effective Tax Rate | 2.90% |
Stock Price Statistics
The stock price has increased by +5.00% in the last 52 weeks. The beta is 1.63, so ARQT's price volatility has been higher than the market average.
| Beta (5Y) | 1.63 |
| 52-Week Price Change | +5.00% |
| 50-Day Moving Average | 27.17 |
| 200-Day Moving Average | 25.34 |
| Relative Strength Index (RSI) | 38.72 |
| Average Volume (20 Days) | 2,558,384 |
Short Selling Information
The latest short interest is 20.49 million, so 16.20% of the outstanding shares have been sold short.
| Short Interest | 20.49M |
| Short Previous Month | 21.69M |
| Short % of Shares Out | 16.20% |
| Short % of Float | 21.85% |
| Short Ratio (days to cover) | 6.13 |
Income Statement
In the last 12 months, ARQT had revenue of $508.68 million and earned $29.91 million in profits. Earnings per share was $0.22.
| Revenue | 508.68M |
| Gross Profit | 463.81M |
| Operating Income | 35.16M |
| Pretax Income | 30.80M |
| Net Income | 29.91M |
| EBITDA | 37.41M |
| EBIT | 35.16M |
| Earnings Per Share (EPS) | $0.22 |
Balance Sheet
The company has $259.46 million in cash and $123.82 million in debt, with a net cash position of $135.64 million or $1.07 per share.
| Cash & Cash Equivalents | 259.46M |
| Total Debt | 123.82M |
| Net Cash | 135.64M |
| Net Cash Per Share | $1.07 |
| Equity (Book Value) | 243.97M |
| Book Value Per Share | 1.94 |
| Working Capital | 331.33M |
Cash Flow
In the last 12 months, operating cash flow was $59.96 million and capital expenditures -$255,000, giving a free cash flow of $59.71 million.
| Operating Cash Flow | 59.96M |
| Capital Expenditures | -255,000 |
| Depreciation & Amortization | 2.25M |
| Net Borrowing | n/a |
| Free Cash Flow | 59.71M |
| FCF Per Share | $0.47 |
Margins
Gross margin is 91.18%, with operating and profit margins of 6.91% and 5.88%.
| Gross Margin | 91.18% |
| Operating Margin | 6.91% |
| Pretax Margin | 6.06% |
| Profit Margin | 5.88% |
| EBITDA Margin | 7.35% |
| EBIT Margin | 6.91% |
| FCF Margin | 11.74% |
Dividends & Yields
ARQT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -6.17% |
| Shareholder Yield | -6.17% |
| Earnings Yield | 0.85% |
| FCF Yield | 1.84% |
Analyst Forecast
The average price target for ARQT is $39.13, which is 53.45% higher than the current price. The consensus rating is "Buy".
| Price Target | $39.13 |
| Price Target Difference | 53.45% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 31.02% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ARQT has an Altman Z-Score of 5.61 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.61 |
| Piotroski F-Score | 7 |